CEMIP: A Potential Drug Target and Biomarker for Transmembrane Protein 2-Like

Target Name: CEMIP

NCBI ID: G57214

CEMIP

CEMIP: A Potential Drug Target and Biomarker for Transmembrane Protein 2-Like

Introduction

Transmembrane protein 2-like (TMP2L) is a protein that plays a crucial role in various physiological processes in the body. It is involved in cell signaling, neurotransmission, and inflammation. The dysfunction of TMP2L has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. CEMIP (Transmembrane protein 2-like) is a potential drug target and biomarker that can be targeted to treat these diseases.

CEMIP: Structure and Function

CEMIP is a 21-kDa transmembrane protein that contains a unique N-terminal region, a catalytic C-terminus, and a unique C-terminal region that is rich in conserved secondary structure elements. CEMIP is expressed in various tissues and cells in the body and is involved in various cellular processes, including cell signaling, neurotransmission, and inflammation.

CEMIP is a key regulator of the protein kinase CKL (Ca2+-dependent protein kinase) kinase activity. CKL is a calcium ion-dependent enzyme involved in cell signaling and neurotransmitter transmission. Research shows that CEMIP regulates cell signaling and neurotransmitter transmission by binding to CKL and inhibiting its activity.

CEMIP is also involved in the regulation of intracellular inflammatory responses. It plays a key role in the inflammatory process and can inhibit the infiltration of immune cells into tissues, thereby reducing the inflammatory response.

Biological activity of CEMIP

The biological activity of CEMIP is mainly manifested in the following aspects:

1. Cell signaling: CEMIP is an important player in the cell signaling process. It regulates cell signaling by binding to CKL and inhibiting its activity.

2. Neurotransmitter transmission: CEMIP is involved in neurotransmitter transmission, including the release and reuptake of neurotransmitters. Studies have shown that CEMIP plays an important role in neuronal survival and synaptic transmission.

3. Regulation of intracellular inflammatory response: CEMIP plays a key role in the regulation of intracellular inflammatory response. It can inhibit the infiltration of immune cells into tissues, thereby reducing the inflammatory response.

4. Antioxidant effect: CEMIP has an antioxidant effect in cells and can scavenge free radicals in cells, thereby protecting cells from oxidative stress damage.

The pharmacological significance of CEMIP

CEMIP is a potential drug target that can be used to treat a variety of diseases. Here are some possible drug targets:

1. Neurodegenerative diseases: CEMIP plays an important role in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. These diseases are associated with neuronal death and damage. By inhibiting the activity of CEMIP, neuronal death and damage can be slowed down, thereby improving the treatment effect of the disease.

2. Treatment of inflammatory diseases: CEMIP has potential application value in the treatment of inflammatory diseases. For example, it can inhibit the infiltration of immune cells into tissues and reduce the inflammatory response, thereby alleviating the symptoms of inflammatory diseases.

3. Tumor treatment: CEMIP also has potential application value in tumor treatment. Research shows that CEMIP can inhibit the growth and metastasis of tumor cells, thereby improving the efficiency of tumor treatment.

4. Cardiovascular disease: CEMIP also plays an important role in cardiovascular disease. It can regulate cell signaling and participate in myocardial contraction and relaxation processes. By inhibiting the activity of CEMIP, the therapeutic effect of cardiovascular disease can be improved.

in conclusion

CEMIP is a potential drug target that can be used to treat a variety of diseases. By inhibiting the activity of CEMIP, neuronal death and damage can be slowed down, thereby improving the treatment effect of the disease. In addition, CEMIP can also inhibit the infiltration of immune cells into tissues and reduce the inflammatory response, thereby alleviating the symptoms of inflammatory diseases.

Protein Name: Cell Migration Inducing Hyaluronidase 1

Functions: Mediates depolymerization of hyaluronic acid (HA) via the cell membrane-associated clathrin-coated pit endocytic pathway. Binds to hyaluronic acid. Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product, a process that may occur through rapid vesicle endocytosis and recycling without intracytoplasmic accumulation or digestion in lysosomes. Involved in hyaluronan catabolism in the dermis of the skin and arthritic synovium. Positively regulates epithelial-mesenchymal transition (EMT), and hence tumor cell growth, invasion and cancer dissemination. In collaboration with HSPA5/BIP, promotes cancer cell migration in a calcium and PKC-dependent manner. May be involved in hearing

The "CEMIP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEMIP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets